Thursday, December 22, 2022 4:20:39 PM
Institutionals shorting this unmercilessly. Three trades totalling 2.4M total shares bought at 4 pm. @ .20 cent profit a share come to $468k.
Recent GOSS News
- GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Placebo Response Risks: SueWallSt • PR Newswire (US) • 05/21/2026 01:00:00 PM
- The Gross Law Firm Reminds Gossamer Bio, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 1, 2026 - GOSS • PR Newswire (US) • 05/19/2026 01:00:00 PM
- Gossamer Bio Shares Decline After Wider-Than-Expected Q1 Loss Despite Revenue Beat (GOSS) • IH Market News • 05/18/2026 02:14:14 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/18/2026 11:08:38 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/18/2026 11:07:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 11:06:58 AM
- Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support • Business Wire • 05/18/2026 11:05:00 AM
- Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update • Business Wire • 05/18/2026 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:01:42 PM
- Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026 • Business Wire • 05/15/2026 11:01:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/14/2026 08:01:27 PM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 1, 2026 in Gossamer Bio, Inc. Lawsuit - GOSS • PR Newswire (US) • 05/12/2026 01:00:00 PM
- GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Concealed PROSERA Placebo Risk: SueWallSt • PR Newswire (US) • 05/07/2026 01:00:00 PM
- GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misrepresented Patient Enrollment Quality: SueWallSt • PR Newswire (US) • 04/30/2026 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 08:02:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 08:01:21 PM
- GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: SueWallSt • PR Newswire (US) • 04/23/2026 01:00:00 PM
- GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/21/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 08:01:13 PM
- GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSS • PR Newswire (US) • 04/06/2026 09:01:00 AM
- Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – GOSS • Business Wire • 04/03/2026 11:30:00 AM
- Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSS • PR Newswire (US) • 04/03/2026 05:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:22:00 PM
